DIA 2018 Editor’s Take – Celerion

Thought Leader:

Bruce Morimoto, PhD, VP, Scientific Affairs

July 25, 2018      

Dr. Morimoto discusses scientific breakthroughs and their impact on drug development efforts, expertise in vaccine research, and using biomarkers in clinical research.

For more information please visit www.celerion.com/.

Post a Comment

You must be logged in to post a Comment.